BioXcel Therapeutics, Inc. | ||||
NCM : BTAI || Location: United States | ||||
$2.88-0.0 (-0.04%) |
0.06 M | 2.8 - 2.9 | ||
Last Updated:America/New_York | Volume | Day range |
Short Interest
Short Date | Short Interest |
---|---|
March 15, 2024 | 3.139 M |
Feb. 29, 2024 | 3.971 M |
Feb. 15, 2024 | 7.460 M |
Jan. 31, 2024 | 2.456 M |
Jan. 12, 2024 | 2.982 M |
EPS Surprise
Period | Estimate | Actual | Surprise |
---|---|---|---|
12/31/2023 | -0.93 | -0.76 | 18.12% |
09/30/2023 | -1.33 | -1.72 | -29.31% |
06/30/2023 | -1.79 | -1.83 | -2.47% |
03/31/2023 | -1.65 | -1.84 | -11.48% |
12/31/2022 | -1.48 | -1.95 | -32.18% |
Sector | Healthcare | Industry | Biotechnology |
Shares Outstanding | 30.577M | Shares Float | 21.713M |
Short Float | 3.139M | Market Cap | 87.50M |
Institution ownership | 28.53% | Insider ownership | 27.056% |
Earnings Date | 05/06/2024 BMO | Cash Per Share | ? |
Trailing EPS | -6.15 | Forward EPS | -2.06 |